S. Norris

发表

Real‐world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1‐ and 4‐infected patients with diverse comorbidities and comedications: A pooled analysis of post‐marketing observational studies from 13 countries

P. Ferenci, D. Back, S. Bourgeois, 2019, Journal of viral hepatitis.

Hepatitis B virus genotype A and D and clinical outcomes of liver transplantation for HBV‐related disease

M. Rela, N. Heaton, M. Yuen, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection

P. Klenerman, S. Gaudieri, D. Kelleher, 2011, Gut.

Management and outcome of pregnancy in autoimmune hepatitis

M. Heneghan, J. O'grady, S. Norris, 2001, Gut.

Strategies to manage hepatitis C virus (HCV) infection disease burden – volume 2

M. Leshno, J. Mossong, C. Stedman, 2015, Journal of viral hepatitis.

Characteristics and outcomes of acute colitis diagnosed on cross-sectional imaging presenting via the emergency department in an Irish academic medical centre

J. Meaney, S. Norris, D. Kevans, 2020, Irish Journal of Medical Science (1971 -).

Hepatic expression of IL-15 mRNA is associated with liver graft acceptance.

B. Portmann, N. Heaton, D. Doherty, 2003, Transplant immunology.

Increased Frequencies of Circulating IFN-γ-Producing Vδ1(+) and Vδ2(+) γδ T Cells in Patients with Asymptomatic Persistent Hepatitis B Virus Infection.

Margaret A. Taylor, D. Doherty, S. Norris, 2015, Viral immunology.

Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon‐γ or interleukin‐10 are expanded in asymptomatic, E antigen‐negative patients with persistent hepatitis B virus infection

D. Doherty, S. Norris, J. Otegbayo, 2015, Journal of viral hepatitis.

Hepatitis B (prevention).

S. Norris, A. Mohsen, 2007, BMJ clinical evidence.

Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study

M. Barry, C. Walsh, R. Merriman, 2015, BMC Infectious Diseases.

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.

J. Lazarus, R. Marinho, S. Olafsson, 2018, The lancet. Gastroenterology & hepatology.

Role of rapid virological response in prediction of sustained virological response to Peg‐IFN plus ribavirin in HCV / HIV co‐infected individuals

S. Norris, M. Codd, F. Mulcahy, 2008, Journal of viral hepatitis.

Haematological support during peg‐interferon therapy for HCV‐infected haemophiliacs improves virological outcomes

S. Norris, B. White, D. Kevans, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease

S. Norris, D. Ferguson, J. Gormley, 2022, BMJ open gastroenterology.

Letter: proving the benefit of exercise intervention in metabolic associated fatty liver disease—authors' reply

S. Norris, S. Finn, J. B. Moore, 2020, Alimentary pharmacology & therapeutics.

Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin

B. Portmann, M. Heneghan, S. Norris, 2002, Gut.

An Exploration of Depressive Symptoms in Hepatitis C Patients Taking Interferon-alpha: Increase in Sickness Behaviors but not Negative Cognitions.

S. O’Mara, A. O’Dwyer, S. Norris, 2012, Journal of clinical and experimental hepatology.

Telementoring with project ECHO: a pilot study in Europe

Sanjeev Arora, S. Norris, C. Bergin, 2017, BMJ Innovations.

MRI assessment of changes in liver iron deposition post-venesection.

P. Beddy, M. Keogan, S. Norris, 2011, European journal of radiology.

Reply to Calcagno et al.

C. Walsh, M. Barry, S. Schmitz, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe

J. Lazarus, R. Marinho, S. Olafsson, 2017 .

Incidence and Impact of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients with Adenocarcinoma of the Esophagus Treated with Curative Intent

S. Norris, S. Finn, M. Conroy, 2022, World Journal of Surgery.

Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis.

J. Tredger, S. Norris, J. Underhill, 2002, Journal of hepatology.

NP-018 Building capacity within a Hepatitis C treatment model. The validation process for a Hepatitis C pre-treatment pharmacist assessment complex intervention toolkit

S. Norris, C. Bergin, A. O'Leary, 2021, National poster prize winners.

Abdominal rash after transarterial chemoembolization via the right inferior phrenic artery.

C. Farrelly, S. Norris, R. Cooney, 2005, Journal of vascular and interventional radiology : JVIR.

Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response

S. Norris, C. Bergin, S. McKiernan, 2017, PloS one.

Development and initial validation of a short food frequency questionnaire for assessing dietary intakes of non-alcoholic fatty liver disease patients

S. Norris, K. Hart, J. B. Moore, 2018, Proceedings of the Nutrition Society.

The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source

D. Kelleher, S. Norris, B. White, 2007, Journal of viral hepatitis.

Hepatitis C (chronic).

S. Norris, A. Mohsen, 2008, BMJ clinical evidence.

Liver stiffness changes during meal times

S. Norris, J. Chin, P. McCormick, 2014, Hepatology.

Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 2

M. Leshno, J. Mossong, C. Stedman, 2015, Journal of viral hepatitis.

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Gamal Esmat, Rui Tato Marinho, Mel Krajden, 2017, The lancet. Gastroenterology & hepatology.

Hepatitis C and HIV-1 coinfection

P. Easterbrook, S. Norris, C. Taylor, 2002, Gut.

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.

M. Manns, V. de Lédinghen, M. Buti, 2017, The lancet. Gastroenterology & hepatology.

Advancing the global public health agenda for NAFLD: a consensus statement

Myeong Jun Song, R. Malekzadeh, V. Wong, 2021, Nature Reviews Gastroenterology & Hepatology.

Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults

B. Portmann, M. Rela, N. Heaton, 2001, Hepatology.

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation

M. Rela, N. Heaton, J. O'grady, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Outcomes of liver transplantation in HIV‐infected individuals: The impact of HCV and HBV infection

B. Portmann, M. Rela, N. Heaton, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients

Christopher M. Taylor, P. Easterbrook, B. Portmann, 2003, Gut.

Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study

P. Plunkett, H. Barry, S. Norris, 2016, PloS one.

Mitochondrial toxicity associated with HAART following liver transplantation in an HIV‐infected recipient

S. Norris, A. Knisely, C. Antoniades, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Brain MRI changes in chronic liver disease

S. Norris, D. Macerlaine, S. Skehan, 1997, European Radiology.

The Epidemiology of Hepatitis B Virus Infection

V. Trimble, S. Norris, B. Crowley, 2006 .

Baseline Prevalence and Emergence of Protease Inhibitor Resistance Mutations following Treatment in Chronic HCV Genotype-1-Infected Individuals

M. Carr, S. Norris, C. Bergin, 2015, Antiviral therapy.

Direct costs of interferon‐based and interferon‐free direct‐acting antiviral regimens for the treatment of chronic hepatitis C infection

S. Norris, A. O'Leary, E. Gray, 2016, Journal of viral hepatitis.

• Nearly a third of the world's population has been infected by hepatitis B at some point, and at least 350 million people have become chronic carriers. Progressive liver damage occurs in up to 25% of carriers.

S. Norris, A. Mohsen, 2009 .

Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection.

P. Donaldson, A. Burt, S. Norris, 2006, Gut.

Apolipoprotein ε3 allele is associated with persistent hepatitis C virus infection

P. Donaldson, S. Norris, M. Bassendine, 2005, Gut.

Risk factors for the development of depression in patients with hepatitis C taking interferon-α

S. O’Mara, S. Norris, C. O’Farrelly, 2011, Neuropsychiatric disease and treatment.

Risk factors for the development of depression in patients with hepatitis C taking interferon-α : a review of literature

S. O’Mara, S. Norris, C. O’Farrelly, 2010 .

National scientific medical meeting 1995 abstracts

G. R. Fitzgerald, W. K. Cullen, M. Rowan, 1995, Irish journal of medical science.

Progression of hepatitis C in the haemophiliac population in Ireland, after 30 years of infection in the pre‐DAA treatment era

S. Norris, B. White, C. Bergin, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Effect of Immune Pressure on Hepatitis C Virus Evolution: Insights From a Single-Source Outbreak

M. John, I. James, P. Klenerman, 2011, Hepatology.

Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients.

J. Lambert, S. Coughlan, W. Hall, 2009, Viral immunology.

Irish Society of Gastroenterology

P. Mccarthy, M. Goggins, M. Kerin, 1995 .

In vitro blood cell responsiveness to IFN-α predicts clinical response independently of IL28B in hepatitis C virus genotype 1 infected patients

S. Norris, S. Stewart, N. Stevenson, 2014, Journal of Translational Medicine.

The advent of successful organ transplantation in the Irish HIV positive cohort

J. O'grady, S. Norris, C. Bergin, 2012, Irish Journal of Medical Science.

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm – volume 2

M. Leshno, J. Mossong, C. Stedman, 2015, Journal of viral hepatitis.

Do disparities between populations in randomized controlled trials and the real world lead to differences in outcomes?

Aisling O'Leary, Emma Gray, Susanne Schmitz, 2017, Journal of comparative effectiveness research.

Gallbladder wall variceal haemorrhage with associated rupture: a rare cause of mortality in the cirrhotic patient.

S. Norris, D. Kevans, R. Macnicholas, 2009, European journal of gastroenterology & hepatology.

Hematochezia in a patient with liver cirrhosis

R. Cahill, S. Norris, R. Stephens, 2007, World journal of emergency surgery : WJES.

Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry

S. Norris, D. Pasta, A. O'Leary, 2017, BMC Health Services Research.

Cardiac Magnetic Resonance at 3.0 T in Patients With C282Y Homozygous Hereditary Hemochromatosis

J. Meaney, A. Fagan, J. Walsh, 2022, Journal of thoracic imaging.

Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma

S. Norris, N. Nolan, M. Iqbal, 2017, Case Reports in Gastroenterology.

Improvement in histological endpoints of MAFLD following a 12‐week aerobic exercise intervention

P. Beddy, S. Norris, S. Finn, 2020, Alimentary pharmacology & therapeutics.

Improvements in cardiac function detected using echocardiography in patients with hereditary haemochromatosis

J. Walsh, S. Norris, C. Daly, 2019, Irish Journal of Medical Science.

Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)

S. Norris, P. O'Gorman, 2021, BMJ open gastroenterology.

Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.

S. Coughlan, W. Hall, A. Grogan, 2007, The Journal of infectious diseases.

The Impact of Diabetes Mellitus on Fibrosis Progression in Patients Transplanted for Hepatitis C

B. Portmann, M. Heneghan, J. O'grady, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1.

M. Barry, C. Walsh, S. Schmitz, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of psoriasis in patients with alcoholic liver disease

S. Norris, B. Kirby, A. Tobin, 2009, Clincal and Experimental Dermatology.

Upper gastrointestinal bleeding: predictors of risk in a mixed patient group including variceal and nonvariceal haemorrhage

J. Reynolds, W. Shields, S. Norris, 2012, European journal of gastroenterology & hepatology.

Irish Society of Gastroenterology

J. Wang, H. Redmond, D. Bouchier-Hayes, 1994, Irish Journal of Medical Science.

Liver transplantation for HCV‐related cirrhosis in a patient with gastric mucosa‐associated lymphoma (MALToma) pretreated with rituximab

G. Mufti, J. O'grady, S. Norris, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Development and relative validation of a short food frequency questionnaire for assessing dietary intakes of non-alcoholic fatty liver disease patients

S. Norris, K. Hart, N. Hancock, 2019, European Journal of Nutrition.

Improvement in cognitive impairment following a 12‐week aerobic exercise intervention in individuals with non‐cirrhotic chronic hepatitis C

K. O’Brien, C. Doherty, R. Coen, 2020, Journal of viral hepatitis.

Peginterferon-alpha-2a and ribavirin combination therapy in chronic hepatitis C infection

A. Grogan, S. McKeirnan, S. Norris, 2006 .

Acute renal failure in orthotopic liver transplantation

G. Mcentee, S. Norris, O. Traynor, 1996, Irish journal of medical science.

High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic

S. Norris, F. Mulcahy, C. Bergin, 2011, International journal of STD & AIDS.

Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970s.

J. Crowe, S. Norris, S. Stewart, 2017, Journal of Hepatology.